Data from independent, pooled analysis show significantly improved risk predictions over clinical variables for tissuecypher® barrett's esophagus test and ability to identify patients at high risk of progressing to esophageal cancer

Friendswood, texas--(business wire)---- $cstl #barrettsesophagus--castle announced an independent, peer-reviewed article in clinical gastroenterology and hepatology for its tissuecypher® barrett's esophagus test.

CSTL Ratings Summary

CSTL Quant Ranking